- Clear All
- Remove thePharmacologyfilter Pharmacology
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove thePharmacies & prescriptionsfilter Pharmacies & prescriptions
- Remove theResearchfilter Research
- Remove theAVMA governance & leadershipfilter AVMA governance & leadership
- Remove thePreventive carefilter Preventive care
AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
AVMA news
FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat Giardia duodenalis in dogs.
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
FDA extends educational period for new policy on compounding animal drugs from bulk drug substances
The Food and Drug Administration has delayed enforcement of its finalized guidance regarding compounding animal drugs from bulk drug substances.
AVMA news
New listings in AVMA Animal Health Studies Database – August 2022
A new study in the AVMA Animal Health Studies Database looks at a gene’s enzymatic activity in dogs with immune thrombocytopenia to further…
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
AVMA news
A private practice teams up with the USDA to study drug use, resistance
Federal animal health authorities are working with a private veterinary services company to analyze the impact of antimicrobial administration on…
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
Compounding guidance for veterinarians
Learn about the regulatory parameters, quality control assurance, and practice considerations when using compounded products in veterinary medicine.
JAVMA news
People ingesting veterinary-use ivermectin in attempts to prevent, cure COVID-19
Health authorities are again warning people not to consume veterinary-use ivermectin products as poison control centers receive a surge in calls about…
JAVMA news
In video, FDA urges adverse event reporting
Whenever an animal drug is linked to an adverse event—in an animal or a person—Food and Drug Administration officials want to know about it.
JAVMA news
FDA wants to bring more antimicrobials under veterinarian control
Federal regulators plan to give veterinarians oversight of all animal uses of antimicrobials considered important for human medicine.
JAVMA news
Seresto collars come under greater scrutiny
Recent adverse event reports from pet owners related to a popular brand of flea and tick collars have gained national attention. The manufacturer has…
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
JAVMA news
Guiding drug use, changing practices
When veterinarians are considering how to treat infections, AVMA officials hope a new report will help bring a panel of experts into the room. And…
JAVMA news
FDA warns companies illegally selling CBD products
Agency signaled that it cannot conclude cannabidiol is safe.
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
In Short
Osteosarcoma is genetically similar in dogs and human children, according to a study published July 19 in the journal Communications Biology by Tufts…
JAVMA news
CWD vaccine delays illness in mice
Several vaccine candidates could prolong lives of animals infected with chronic wasting disease and reduce spread of the disease.
JAVMA news
FDA opens access to adverse event data
The Food and Drug Administration is offering data about adverse events in animals that can be useful for researchers and software developers.
JAVMA news
Report supports rational administration of gastroprotectants to dogs and cats
Concerns have been raised that, as in human patients, acid suppressants are being overprescribed and misused in canine and feline patients.
JAVMA news
In Short
The Great Barrier Reef's only endemic mammal may be the first mammalian extinction from human-caused climate change.
JAVMA news
FDA sees trend of unsafe compounding labs
Food and Drug Administration authorities say they are seeing a trend of unsafe conditions in compounding laboratories.